Abstract
S38 Efficacy and Safety of Nonmedical Switching From Infliximab Originator to Infliximab Biosimilar CT-P13 in Patients With Inflammatory Bowel Disease, A Single-Center Prospective Study in Japan
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have